title: Voriconazole-Induced Subacute Cutaneous Lupus Erythematosus in an Adult With Aspergillosis.
abstract: A 59-year-old man was treated with voriconazole for chronic invasive aspergillosis and who subsequently developed subacute cutaneous lupus erythematosus (SCLE). The patient presented with a 6-week history of multiple erythematous papulosquamous lesions on his chest, upper and lower extremities, and back (Figure 1). They were nonpruritic and nonpainful. He was afebrile and otherwise well. He had no history of extensive sun exposure prior to the appearance of the eruption. He had been taking voriconazole for about 3 months prior to the onset of lesions. He denied any family history of connective tissue disease.
authors.affiliation: Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN; navid.ezra@gmail.com.
authors.forename: Navid
authors.initials: N
authors.lastname: Ezra
authors.affiliation: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Natanel
authors.initials: N
authors.lastname: Jourabchi
authors.affiliation: Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN.
authors.forename: Nico
authors.initials: N
authors.lastname: Mousdicas
mesh_terms: D000935:Antifungal Agents / Q000009:adverse effects*; D001228:Aspergillosis / Q000188:drug therapy*; D002908:Chronic Disease; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D065819:Voriconazole / Q000009:adverse effects*
chemical_list: D000935:Antifungal Agents; D065819:Voriconazole